Female Problems: Women’s Health Mustn’t be Ghettoized in the Uterus Peter J. Pitts Commentary 24 January 2024 Pages: 75 - 77
Potential of Artificial Intelligence to Accelerate Drug Development for Rare Diseases Giulio NapolitanoCanan HasCarsten Ullrich Leading Article 05 February 2024 Pages: 79 - 86
Advancing Rheumatology Care Through Machine Learning Thomas Hügle Leading Article Open access 29 February 2024 Pages: 87 - 96
Why Oncology Global Safety Teams Should Develop the Safety Section of the Study’s Target Product Profile (TPP) Michael E. Kieffer Current Opinion 27 February 2024 Pages: 97 - 108
Decentralisation in Clinical Trials and Patient Centricity: Benefits and Challenges Shubhadeep D. SinhaSreenivasa Chary SriramadasuSudeshna Roy Review Article 07 March 2024 Pages: 109 - 120
Emergency Approval Mechanisms for Human Vaccines in India Nidhi MehrotraPadmavati Manchikanti Review Article 24 January 2024 Pages: 121 - 132
Meaningful Within-Patient Change in Subjective Total Sleep Time in Patients with Insomnia Disorder: An Analysis of the Sleep Diary Questionnaire Using Data from Open-Label and Phase III Clinical Trials Andrea Phillips-BeyerAriane K. KawataBruno Flamion Original Research Article Open access 01 February 2024 Pages: 133 - 144
Physician Awareness of the Safe Use of Cyproterone Acetate in Europe: A Survey on the Effectiveness of Additional Risk Minimization Measures Carolyn SweeneyAlicia GilsenanFederica Pisa Original Research Article Open access 31 January 2024 Pages: 145 - 156